EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE Lisbon, Portugal
|
|
|
- Mark Blake
- 5 years ago
- Views:
Transcription
1 EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE 2019 Lisbon, Portugal
2 Mapping the new world of allergy" at EAACI Congress 2019 This year we will offer you an innovative scientific programme, articulated around the theme of: Mapping the new world of allergy: towards precision medicine in allergy and asthma. Explore some of the key topics and issues that will be discussed... Biologics and small molecules: therapeutic effects and mechanisms of available targeted therapies for severe asthma. Biomarkers: monitoring treatment response and allowing the identification of responders to targeted therapies. Immune tolerance in the gut. The relevance of the exposome. New treatment directions: the use of allergoids, recombinant allergens, conventional sublingual, subcutaneous, and epicutaneous allergen immunotherapy treatment. Asthma Food allergy The underpinning mechanisms of how neonatal gut microbiota associates with childhood allergy, novel strategies of preventing food allergy by targeting the microbiome. Prevention, challenges faced by allergic young adults, development and remission of asthma during childhood. Pediatrics State of the Art of current and novel approaches of allergen immunotherapy. Recent EAACI efforts in improving clinical trials designs in the era of evidence-based medicine. Unmet needs in allergen immunotherapy research. Allergen immunotherapy Efficient diagnostic tests, including a novel algorithm for classification of cutaneous manifestations for drug hypersensitivity, and therapeutic approaches for management. Cross-reactivity, new sensitizations, multiple drug hypersensitivity syndrome, the role of viruses. Drug allergy Microbial influence on skin inflammation, new treatment modalities in atopic dermatitis e.g. biologics. Skin barrier modulation in atopic dermatitis; upcoming allergens in allergic contact dermatitis; treatment of chronic spontaneous urticaria. Dermatology
3 EAACI Congress 2019 features... EAACI-UEMS Exam - Pediatric track 8 interactive PG Courses 2 Special Sessions: Allied Health Day and Luso-Brazilian Joint Symposium 10 Interactive Workshops 12 Learning Lounges 25 Business Meetings 1 EAACI Course: Update and new concepts in basic and translational immunology 7 Plenary Symposia 45 Symposia 13 Sister Society Symposia 3 Interactive Symposia 6 Pro/Con Sessions Highlight Sessions in Pro/Con Arena - available for educational grant JM Session: Scientific, Educational, Case Report 5 Hot Topic sessions 6 Year in Review
4 Scientific Programme Overview Plenary symposia New concepts in food allergy Sunday 2 June New insights in skin hypersensitivity Sunday 2 June Immune tolerance in the intestine Exposome and food allergy Can food allergy be cured? Pathophysiology: Epidermal barrier and immune imbalance What is the impact of the microbiome on atopic dermatitis New treatments in the pipeline Fueling the immunity: from immunometabolism to novel treatment strategies Monday 3 June Bio- "logic" approaches in Asthma Monday 3 June Innate immune cells and immunometabolism for novel therapeutic interventions Metabolic reprogramming in T cells as a target of immunotherapy Translating new concepts in metabolomics into allergy interventions Type 2 targeted therapies: Biologicals vs. small molecules Non-type 2 asthma: clinical approach and treatment options Current biological options for children with asthma &future opportunities
5 The link between allergy and the microbiome Allergy today - Targeting barriers and tolerance Tuesday 4 June Tuesday 4 June Neonatal gut microbiota, childhood multisensitisation and T-cell differentiation Influence of Lung microbiome on fungal associated asthma Impact of diet-microbiome on mucus barrier and immune disorders Barrier dysfunction- the "Achilles heel" of allergic diseases? Targeting the molecules and mediators - "magic bullets" for allergy treatment Biodiversity - is it important for tolerance? The preliminary programme will be published mid- November. Allergen Immunotherapy: Conceptualising the future and beyond Wednesday 5 June Aeroallergen AIT: Evidence meets innovations Clinical trials: Improving trial designs in the age of evidence based medicine Evidence gaps and research priorities in Allergen Immunotherapy
6 Interactive Postgraduate Courses (IPCG) Half-day sessions with speaker presentations, designed to provide a thorough review of a special interest area and to enhance peer-to -peer learning and networking. IPCGs can be at the basic level or advanced level, and are merged with visits to the Clinical Village, where attendees can actively try out different procedures and equipment used in the diagnosis and treatment of allergic diseases. IPGC 1 (Basic): Management of drug hypersensitivity in children IPGC 2 (Basic): Allergen Immunotherapy IPGC 3 (Advanced): Implementing molecular allergology and cellular testing in allergy diagnostics 2019 IPGC 4 (Basic): Non-IgE mediated Food Allergy IPGC 5 (Basic): Practical management of IgEmediated food allergy IPGC 6 (Advanced): Understanding Immunological pathways of the new biological therapies IPGC 7 (Advanced): Big data revolutionintegrating various omics datasets IPGC 8 (Basic): Bronchial provocation challenges for diagnosing exercise-induced asthma in adults Learning Lounges (LL) Learning Lounges allow delegates to meet in a small group with outstanding researchers and clinicians. The format is designed to facilitate informal discussions, allowing participants to present their questions and gain new insights. No presentations will be given, instead the participants will have ample time for interaction with the faculty member and their peers. LL 1: Decision making in prescribing biologicals in children LL 2: Allergen immunotherapy Basic and clinical perspective LL 3: Managing nut allergy LL 4: What to consider when setting up allergy animal models LL 5: Treatment Options in severe ocular allergy LL 6: Educating the food allergic patient for a better QOL: practical issues LL 7: Implement Component-resolved diagnostics in Allergy LL 8: Treatable traits in Asthma: Can it predict exacerbations? LL 9: Anti IgE for treatment of chronic urticaria LL 10: Which skin tests can be used for delayed cutaneous adverse drug reactions? LL 11: How to evaluate Lung function in the asthmatic child LL 12: Endotyping chronic rhinosinusitis for a better treatment approach
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Basics of Pediatric Allergy. Academic year 2015/2016. Mirjana Turkalj
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Basics of Pediatric Allergy Academic year 2015/2016 I. COURSE AIMS COURSE OUTLINE The specialty of allergy involves the management of a wide range
Ioana Agache Transylvania University Brasov. Precision medicine in allergy and asthma
Ioana Agache Transylvania University Brasov Precision medicine in allergy and asthma Precision medicine and precision health Personalized care based on molecular, immunologic and functional endotyping
Concept paper on a Guideline for allergen products development in moderate to low-sized study populations
1 2 3 4 5 6 7 13 December 2018 EMA/CHMP/251023/2018 Rheumatology / Immunology Working Party (RIWP) Concept paper on a Guideline for allergen products development in moderate to low-sized study populations
review article AN IDEAL CHILDREN S CHEST AND ALLERGY CLINIC
AN IDEAL CHILDREN S CHEST AND ALLERGY CLINIC Adéle Pentz, Dip Allerg(SA), Carla Els, Dip Allerg(SA), Cert Pulm(SA)(Paed), Odette Coetzee, Nat Dip Clin Tech, Robin J Green, PhD, DSc Correspondence Department
13th ECE Vienna - PROGRAMME AT A GLANCE
Neurobiology Symposium 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday
21 st Century Cures Initiative
STATEMENT OF THE AMERICAN ACADEMY OF ALLERGY, ASTHMA AND IMMUNOLOGY TO THE HOUSE COMMITTEE ON ENERGY AND COMMERCE on the 21 st Century Cures Initiative June 13, 2014 The American Academy of Allergy, Asthma
13th ECE - Programme at a Glance
Neurobiology 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday 27th August
13th ECE Vienna - PROGRAMME AT A GLANCE
Neurobiology 14.30-16.00 Sunday 26th August Neonatal Session (5) seizure 14.30-16.00 guidelines 14.00-16.30 Set Up ~ Posters on Display all day ~ Authors present (14.00-14.40) Take Dow Monday 27th August
Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
Pediatrics Update 2017 July 31 August 10, Detailed Conference Agenda
Pediatrics Update 2017 July 31 August 10, 2017 Detailed Conference Agenda Please Note: Out of respect for your fellow delegates, please arrive at least 5 minutes prior to each session. The sessions will
Outcomes Summary. February 3-6, 2016 Keystone, Colorado
Outcomes Summary February 3-6, 2016 Keystone, Colorado Executive Summary Activity Details Background: The National Jewish Health Annual The Pulmonary and Allergy Update highlights insights and recent advances
Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication
( Genentech, Inc., Novartis Pharmaceuticals Corp.) September 2003 Indication The FDA recently approved Omalizumab on June 20, 2003 for adults and adolescents (12 years of age and above) with moderate to
NEW ADVANCES IN CANINE ALLERGIC DISEASE
PROCEEDINGS OF A SYMPOSIUM HELD AT THE 8 TH WORLD CONGRESS OF VETERINARY DERMATOLOGY I BORDEAUX, FRANCE 1 st JUNE 2016 NEW ADVANCES IN CANINE ALLERGIC DISEASE ZOETIS PRINCIPAL SPONSOR OF THE 8 TH WCVD
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease
An Insight into Allergy and Allergen Immunotherapy Co-morbidities of allergic disease Carmen Vidal Athens, September 11, 2014 Pucci S & Incorvaia C, 2008; 153:1-2 1. The major player in driving the immune
Day at a Glance Schedule Saturday, April 22, 2017 Nutrition Across. Nutritional Nutrition
American Society for Scientific Sessions at EB 2017 Day at a Glance Schedule Friday, April 21, 2017 All functions will be held at the McCormick Place Convention Center unless otherwise indicated. Updated
Foundations of Clinical Medicine MS1 - COM Fall /7/2017-9/22/2017
Weeks Date Time Title Faculty Week 1 Foundations of Clinical Medicine MS1 - COM 501 - Fall 2017 8/7/2017-9/22/2017 Monday, 8/7/17 8:00-8:30 am Introduction to Foundations Ely Monday, 8/7/17 8:30-9:00 am
Allergens And Allergen Immunotherapy Fourth Edition Clinical Allergy And Immunology
Allergens And Allergen Immunotherapy Fourth Edition Clinical Allergy And Immunology 1 / 6 2 / 6 3 / 6 Allergens And Allergen Immunotherapy Fourth areas of allergens and immunotherapies: pollens animal/insect
Allergy Update. because you depend upon results. Abacus ALS
Allergy Update Abacus ALS ALS ImmunoCAP sigg measurement ImmunoCAP Specific IgG Measures antigen-specific IgG antibodies in human serum and plasma. Part of the natural defence system of the body and develop
Immunology of Asthma. Kenneth J. Goodrum,Ph. Ph.D. Ohio University College of Osteopathic Medicine
Immunology of Asthma Kenneth J. Goodrum,Ph Ph.D. Ohio University College of Osteopathic Medicine Outline! Consensus characteristics! Allergens:role in asthma! Immune/inflammatory basis! Genetic basis!
NIH Public Access Author Manuscript J Invest Dermatol. Author manuscript; available in PMC 2015 February 01.
NIH Public Access Author Manuscript Published in final edited form as: J Invest Dermatol. 2014 August ; 134(8): 2071 2074. doi:10.1038/jid.2014.141. A possible role for IL-17A in establishing Th2 inflammation
Persistent food allergy might present a more challenging situation. Patients with the persistent form of food allergy are likely to have a less
Iride Dello Iacono Food allergy is an increasingly prevalent problem in westernized countries, and there is an unmet medical need for an effective form of therapy. A number of therapeutic strategies are
Anti-IgE: beyond asthma
Anti-IgE: beyond asthma Yehia El-Gamal, MD, PhD, FAAAAI Professor of Pediatrics Pediatric Allergy and Immunology Unit Children s Hospital, Ain Shams University Member, WAO Board of Directors Disclosure
Is there an allergy epidemic and what are the possible causes?
Is there an allergy epidemic and what are the possible causes? Professor Michael Gold Department of Allergy and Immunology Women s and Children s Health Network Discipline of Paediatrics University of
REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC296DFR PUBLICATION DATE NOVEMBER 2013 DUPILUMAB (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Dupilumab in the nine major pharmaceutical markets
Infographic (right): ESMO 2014 record breaking Congress
ESMO 2014 Congress Scientific Meeting Report Precision Medicine in Cancer Care 26-30 September 2014 Madrid, Spain Summary The European Society for Medical Oncology (ESMO) Congress, held September 26 to
Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
Preliminary Program Outline
Saturday, June 2, 2018 1:00 pm 5:30 pm Pre-Meeting Symposia Advanced Immunology Basic Science for the Clinician The Immunology of Kidney Transplantation Transplant Center QAPI and Advanced Leadership:
Pro/Con: Pets Prevent Allergies and Asthma
Slide 1 Pro/Con: Pets Prevent Allergies and Asthma Slide 2 Special thanks to: n Dr. Dennis Ownby n Dr. Matt Perzanowski n Dr. Erica von Mutius and Dr. Charlotte Braun-Fahrlander n Dr. Andy Liu n Colleagues
Recognition & Management of Anaphylaxis in the Community. S. Shahzad Mustafa, MD, FAAAAI
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures None Outline Define anaphylaxis Pathophysiology Common causes Recognition and Management Definition Acute,
SWHPN 2018 Call for Abstracts: Guidelines for Submitting an Abstract
SWHPN 2018 Call for Abstracts: Guidelines for Submitting an Abstract The Social Work Hospice and Palliative Care Network invites you to submit an abstract for the 2018 General Assembly. This Assembly will
International Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program*
International Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program* *Subject to change Pre-Conference Days May 25-26 May 25 - Pre-Conference: Noninvasive Brain Stimulation
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.
Allergy and Immunology Review Corner: Chapter 75 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al. Chapter 75: Approach to Infants and Children with Asthma
Job Description for Locum Consultant in Allergy
Job Description for Locum Consultant in Allergy Number of Posts: 1 Contents 1.0 Role Summary 2.0 Key Duties and Responsibilities 3.0 The Allergy and Clinical Immunology Department 4.0 Job Plan/On-Call
IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB
IAS Conference Vienna 18 th to 23 rd July 2010 overview Paul Clift King s College Hospital/UK-CAB Overall Conference I c. 25,000 participants Covers everything HIV-related Several Pre-conferences: Faith,
ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS
ALLERGY AND CLINICAL IMMUNOLOGY FELLOWSHIP PROGRAM DEPARTMENT OF PEDIATRICS I. INTRODUCTION The Pediatric Allergy and Immunology (A&I) Fellowship Program at King Faisal Specialist Hospital and Research
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE. Plan of the course. Allergy and Asthma. Academic year 2017/2018. izv. prof. dr. sc. Asja Stipić Marković
UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE Plan of the course Allergy and Asthma Academic year 2017/2018 I. COURSE AIMS Allergy is the major problem of the 21 century, and this problem is predicted to worsen
Defining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
Defining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma
Defining Asthma: Clinical Criteria Defining Asthma: Bronchial Hyperresponsiveness Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine,
Food Allergy Clinical Trials
Food Allergy Clinical Trials Jacqueline Pongracic, MD Division Head, Allergy/Immunology Professor of Pediatrics and Medicine Northwestern University Feinberg School of Medicine Outline Introduction Approaches
International Society of Microbiota
Targeting Microbiota World Congress 2018 1 Targeting Microbiota World Congress 2018 2 Dear Colleagues, On behalf of the International Society of Microbiota, we are pleased to inform you that the 6th World
7/25/2016. Use of Epinephrine in the Community. Knowledge Amongst Paramedics. Knowledge Amongst Paramedics survey of 3479 paramedics
Recognition & Management of Anaphylaxis in the Community S. Shahzad Mustafa, MD, FAAAAI Disclosures Speaker s bureau Genentech, Teva Consultant Genentech, Teva Outline Knowledge gap Definition Pathophysiology
Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy
Clinical Implications of Asthma Phenotypes Michael Schatz, MD, MS Department of Allergy Definition of Phenotype The observable properties of an organism that are produced by the interaction of the genotype
10 Pediatric Infectious Diseases Congress
allied academies 10 Pediatric Infectious Diseases Congress th September 20-22, 2017 Toronto, Canada Theme: Promulgating the innovative challenges and novel technologies in Pediatric Infectious Diseases
Link and Lead A look in the future and the role of transplant coordinators.
TRANSPLANTATION LEARNING JOURNEY Munich, Germany 6-10 2018 Second announcement 6-7 10 th ELITA 6-7 VCA 7 3 rd ETAHP 7-8 27 th 27 th Congress 3 rd Congress & Workshops Workshops 8 9-10 3 rd 9-10 Link and
UPDATE: 7th World Congress of Veterinary Dermatology
Focus on the Science UPDATE: 7th World Congress of Veterinary Dermatology VANCOUVER JULY 2012 NEW INSIGHTS AND SCIENTIFIC FINDINGS THE WORLD CONGRESS OF VETERINARY DERMATOLOGY organized under the auspices
and its clinical implications
The Immunology of Allergy and its clinical implications By Dr Priya Bowry Sikand MBBS MRCGP DFFP DIC MSc(Allergy) Back to the Basics. Objectives Understand immunological mechanisms behind Type 1 Hypersensitivity
Inflammation in the clinic
Inflammation in the clinic Stephen T. Holgate MRC Clinical Professor of Immunopharmacology ILSI Europe Workshop, Seville, May 14-15 2012 The immune system acts in four general ways to ensure host defence
Test Name Results Units Bio. Ref. Interval ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM (FEIA) 0.42 kua/l
LL - LL-ROHINI (NATIONAL REFERENCE 135091547 Age 28 Years Gender Female 1/9/2017 120000AM 1/9/2017 103610AM 1/9/2017 14658M Ref By Final ALLERGY, INDIVIDUAL MARKER, BANANA, SERUM 0.42 kua/l QUANTITATIVE
Breast Cancer. allied. Theme: Explore New Discoveries in Breast Cancer: Health Promotion and Awareness. 7 th World Congress on
7 th World Congress on allied academies Breast Cancer November 1-2, 2017 Toronto, Canada Theme: Explore New Discoveries in Breast Cancer: Health Promotion and Awareness Dear Prospective Sponsor/Exhibitor,
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024
Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 Atopic Dermatitis - Japan Drug Forecast and Market Analysis to 2024 BioPortfolio has been marketing business and market research reports
Dysbiosis In Human Disease: Pathogenic And Therapeutic Considerations In Diseases Of Sustained Inflammation By Alex Vasquez
Dysbiosis In Human Disease: Pathogenic And Therapeutic Considerations In Diseases Of Sustained Inflammation By Alex Vasquez If looking for the ebook by Alex Vasquez Dysbiosis in Human Disease: Pathogenic
Biologic Therapies for Atopic Dermatitis and Beyond
Biologic Therapies for Atopic Dermatitis and Beyond Jonathan Corren, M.D. Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA Disclosures Genentech - research Medimmune/AZ -
SINGAPORE. 12 th PVRI Annual World Congress. on Pulmonary Vascular Disease WELCOME TO. Date // January 2018
Date // 21-25 January 2018 12 th PVRI Annual World Congress on Disease Hotel // Mandarin Orchard Hotel. Singapore WELCOME TO SINGAPORE Pre-Congress MEETINGS Sunday 21 January 2018 PVRI Board of Directors
Autoimmunity. Autoimmunity Brochure. International Conference on. Autoimmunity Manchester, UK October 13-14, 2016
International Conference on Autoimmunity Manchester, UK October 13-14, 2016 Brochure Conference Secretariat 2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA Ph: +1-888-843-8169, Fax: +1-650-618-1417,
Approach to eczema. Hugo Van Bever Department of Pediatrics NUHS - Singapore
Approach to eczema Hugo Van Bever Department of Pediatrics NUHS - Singapore APAPARI workshop, Yangon, October 30, 2016 Eczema in children 1. Atopic dermatitis 2. Constitutional eczema 3. Contact dermatitis
Disease spectrum. IPA Invasive pulmonary aspergillosis
Aspergillus & ABPA Disease spectrum IPA Invasive pulmonary aspergillosis ABPA ABPA pathophysiology conidia of Aspergillus trapped in mucous and narrowed airways of asthmatics/cf germinate to form hyphae
Scientific Contribution 2018
Allergy in a changing world Scientific Contribution 218 37 th Congress of the European Academy of Allergy and Clinical Immunology EAACI, 26-3 - May 218, Munich, Germany Dear Congress delegate, On behalf
International Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program*
Pre-Conference Days May 25-26 International Neuromodulation Society 14th World Congress May 25-30, 2019, Preliminary Scientific Program* *Subject to change May 25 - Pre-Conference: Noninvasive Brain Stimulation
REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Protopic in the nine major pharmaceutical markets
(26000)=I
Table E1. Literature search Search Cochrane Databases of Systematic Reviews, Database of Abstracts of Reviews of Effectiveness, and Central; Literature search 2015, April 25 th 1. "asthmazoekacties jan
COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012
Drug, Treatment, Device name Omalizumab (Xolair; Novartis) COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012 Licensed indication Omalizumab
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE
CHRONIC URTICARIA, STRIVING AND BUILDING FOR EXCELLENCE BARCELONA 14-15 January 2016 HOSPITAL DEL MAR Passeig Marítim, 25-29 Barcelona 08003 PROGRAM WITH SIMULTANEOUS TRANSLATION Faculty COORDINATORS Giménez-Arnau,
Clinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013
1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT
OUTCOMES SUMMARY REPORT
: Current Perspectives in Asthma, Allergy and Pulmonary Practice OUTCOMES SUMMARY REPORT Live Educational Activity Series September 9, 2016 ME201520772 Executive Summary - Activity Details Background:
REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Elidel in the major pharmaceutical markets: the
The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis and Asthma
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
REFERENCE CODE GDHC183CFR PUBLICAT ION DATE NOVEM BER 2013 ATOPIC DERMATITIS US DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC183CFR PUBLICAT ION DATE NOVEM BER 2013 ATOPIC DERMATITIS Executive Summary Sales for Atopic Dermatitis 2012 in US The US Atopic dermatitis market was worth approximately $1.35 billion
Allergen Immunotherapy in Asthma: Now and in the Future
Allergen Immunotherapy in Asthma: Now and in the Future Young-Il Koh, M.D. Chonnam National University Medical School, Gwangju, Korea 2017-03-25 CHONNAM NATIONAL UNIVERSITY MEDICAL SCHOOL 1 Management
Registration Tuesday, September 25, Wednesday, September 26, 2018
Registration Tuesday, September 25, 2018 2:00-6:00 PM On-Site Registration (FOUNTAIN LOBBY - RIVERSIDE COMPLEX) HOSTED EVENT 3:00-7:00 PM National Psoriasis Foundation for the Allied Health Psoriasis Recognition
ALLERGIES ALLERGY. when the body treats a harmless substance as a threat and the immune system produces an unnecessary response. Trivial (nuisance)
ALLERGY when the body treats a harmless substance as a threat and the immune system produces an unnecessary response Severity of Response Trivial (nuisance) Life altering Fatal (anaphylaxis) Hayfever diagnosed
Allergen-Specific Immunotherapy: Hocus Pocus or Legitimate Therapy Holly Roberts, DVM, MS, DACVD
Allergen-Specific Immunotherapy: Hocus Pocus or Legitimate Therapy Holly Roberts, DVM, MS, DACVD 1. Allergic Disease a. Atopic Dermatitis i. Seasonal ii. Nonseasonal iii. Seasonally nonseasonal b. Cutaneous
Does rhinitis. lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma
Does rhinitis lead to asthma? Does sneezing lead to wheezing? What allergic patients should know about the link between allergic rhinitis and asthma For a better management of allergies in Europe Allergy
Feed those babies some peanut products!!!
Disclosures Feed those babies some peanut products!!! No relevant disclosures Edward Brooks Case presentation 5 month old male with severe eczema starting at 3 months of age. He was breast fed exclusively
EAS Congress Innsbruck Highlights: A programme to excite, inspire and inform!
Press release 84 th European Atherosclerosis Society Congress, Innsbruck, Austria For circulation 29 th May, 2016. 84 th Annual Congress of the European Atherosclerosis Society (EAS) May 29 th - June 1
Appendix 9B. Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy.
Appendix 9B Diagnosis and Management of Infants with Suspected Cow s Milk Protein Allergy. A guide for healthcare professionals working in primary care. This document aims to provide health professionals
SLIT: Review and Update
SLIT: Review and Update Disclosure Speaker: ISTA Pharmaceuticals Speaker: GlaxoSmithKline Allergen IT - Evidence Based Evaluation: Rescue Medications Meta-analysis Disease IT # of Patients Rescue Medication
21 st ANNUAL CLINICAL CYTOMETRY MEETING AND COURSE. LONG BEACH, California October 6-10, 2006 PRELIMINARY PROGRAM
CCS 21 st 1 ANNUAL MEETING 1 21 st ANNUAL CLINICAL CYTOMETRY MEETING AND COURSE LONG BEACH, California October 6-10, 2006 PRELIMINARY PROGRAM For more information visit www.cytometry.org 2 CCS 21 st ANNUAL
DNA vaccine, peripheral T-cell tolerance modulation 185
Subject Index Airway hyperresponsiveness (AHR) animal models 41 43 asthma inhibition 45 overview 41 mast cell modulation of T-cells 62 64 respiratory tolerance 40, 41 Tregs inhibition role 44 respiratory
ALLERGIES ARE A LOW PROFILE HIGH IMPACT DISEASE. MASOOD AHMAD,M.D.
ALLERGIES ARE A LOW PROFILE HIGH IMPACT DISEASE. MASOOD AHMAD,M.D. What Is a Food Allergy? A food allergy is a medical condition in which exposure to a food triggers an IgE mediated immune response. The
What are Allergy shots / SCIT?
Allergy diagnosis must be made accurately with correct history and tests including the skin prick test and the blood test like immunocap / Phadiatop study. This once made will help decide the dose and
Allergy Immunotherapy in the Primary Care Setting
Allergy Immunotherapy in the Primary Care Setting New York State College Health Association 2008 COMBINED ANNUAL MEETING October 2008 Mary Madsen RN BC University of Rochester Issues in Primary Care Practice
Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm
Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria
Pediatric allergy. needs to know. pitfalls: What every physician
Pediatric allergy pitfalls: What every physician needs to know Christine McCusker Associate Professor Division Director Pediatric Allergy, Immunology and Dermatology McGill University Disclosures I am
ACCURATE DIAGNOSIS OF ALLERGIC AIRWAY DISEASES
DEPARTMENT OF OTORHINOLARYNGOLOGY UPPER AIRWAYS RESEARCH LABORATORY ACCURATE DIAGNOSIS OF ALLERGIC AIRWAY DISEASES Prof Dr Philippe GEVAERT DISCLOSURES Phillipe Gevaert, MD, PhD, has disclosed the following
Cutaneous adverse food reactions in the canine patient
Cutaneous adverse food reactions in the canine patient D R. M I C H A E L A. R O S S I, D V M, M N S D I P. A M E R I C A N C O L L E G E O F V E T E R I N A R Y D E R M A T O L O G Y C O A S T A L V E
Recent insights into atopic dermatitis and implications for management of infectious complications
Mark Boguniewicz, MD Professor, Division of Allergy-Immunology Department of Pediatrics National Jewish Health and University of Colorado School of Medicine Denver, Colorado USA Recent insights into atopic
Add on therapy in asthma. Local experience in context J Paul Dilworth, Nicola Marks, Lauren Geddes
Add on therapy in asthma Local experience in context J Paul Dilworth, Nicola Marks, Lauren Geddes Programme Omalizumab Evidence and assessment Local Experience Dysfunctional breathing The other effective
Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)
Line of Business: All Lines of Business Effective Date: August 16, 2017 Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit) This policy has been developed through review
An Update on Allergic Rhinitis. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital
An Update on Allergic Rhinitis Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital Allergic Rhinitis Common condition with increasing prevalence
PROGRAMME AT A GLANCE
PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver
SPONSOR PROSPECTUS ANNUAL MEETING AND CLINICAL LABORATORY EXPO
SPONSOR PROSPECTUS ANNUAL MEETING AND CLINICAL LABORATORY EXPO JULY 29 - AUGUST 2, 2018 SWISSOTEL CHICAGO, ILLINOIS MAKE CONNECTIONS THAT MATTER Access key laboratory decision-makers, purchasers, and influencers
WISC 2019 (Beirut): Thursday, 4 April 2019
WISC 2019 (Beirut): Thursday, 4 April 2019 Last Updated: February 20, 2019 Start End Session (Room: Tyre Hall) Speaker Session (Room: Berytus) Speaker Session (Room: Carthage) Speaker 7:45 8:30 Meet the
INTERNAL MEDICINE FOR PRIMARY CARE PHYSICIANS. San Diego, California Hotel Del Coronado. August 23-26, Participating Faculty
INTERNAL MEDICINE FOR PRIMARY CARE PHYSICIANS San Diego, California Hotel Del Coronado August 23-26, 2012 Participating Faculty David C. Levin, M.D. Professor of Medicine University of Oklahoma Health
RESPIRATORY BLOCK. Bronchial Asthma. Dr. Maha Arafah Department of Pathology KSU
RESPIRATORY BLOCK Bronchial Asthma Dr. Maha Arafah Department of Pathology KSU marafah@ksu.edu.sa Jan 2018 Objectives Define asthma (BA) Know the two types of asthma 1. Extrinsic or atopic allergic 2.
HESI ANNUAL MEETING JUNE 13-15, 2017 DUBLIN IRELAND SCIENCE FORWARD
HESI ANNUAL MEETING JUNE 13-15, 2017 DUBLIN IRELAND SCIENCE FORWARD TUESDAY JUNE 13, 2017 8:30 am 12:00 pm HESI Board of Trustees Meeting Trustees and HESI Committee Leaders Invited. Observers Welcome
Pediatric Dermatology. Dra. Ana Batalla
Pediatric Dermatology Dra. Ana Batalla Special aspects of skin in neonates and infants Prof. Dr. Regina Fölster-Holst. Kiel - Germany. Vernix caseosa facilitates the development of stratum corneum Functions